Epilepsy Research
Volume 31, Issue 2 , Pages 101-112 , July 1998

Effects of lamotrigine and conventional antiepileptic drugs on amygdala- and hippocampal-kindled seizures in rats

  • Kenro Otsuki

      Affiliations

    • Department of Neuropsychiatry, Okayama University Medical School, 2-5-1 Shikata-cho, Okayama 700, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81 86 2237151; fax: +81 86 2357246; e-mail:luna@purple.plala.or.jp
    • ,
  • Kiyoshi Morimoto

      Affiliations

    • Department of Neuropsychiatry, Kagawa Medical School, 1750-1, Miki-cho, Kida-gun, Kagawa 761-07, Japan
    • ,
  • Keiko Sato

      Affiliations

    • Clinical Research Institute, National Sanatorium Minamiokayama Hospital, 4066, Hayashima-cho, Tsukubo-gun, Okayama 701-03, Japan
    • ,
  • Norihito Yamada

      Affiliations

    • Department of Neuropsychiatry, Okayama University Medical School, 2-5-1 Shikata-cho, Okayama 700, Japan
    • ,
  • Shigetoshi Kuroda

      Affiliations

    • Department of Neuropsychiatry, Okayama University Medical School, 2-5-1 Shikata-cho, Okayama 700, Japan

Received 31 October 1997 ,Revised 10 March 1998 ,Accepted 15 March 1998.

References 

  1. Binnie CD, Debets RM, Engelsman M, et al.  Double-blind crossover trial of lamotrigine (Lamictal) as add-on therapy in intractable epilepsy. Epilepsy Res. 1989;4:222–229
  2. Birnstiel S, Haas HL. Anticonvulsants do not suppress long-term potentiation (LTP) in the rat hippocampus. Neurosci. Lett. 1991;14:61–63
  3. Bliss TVP, Collingridge GL. A synaptic model of memory: long-term potentiation in the hippocampus. Nature. 1993;361:31–39
  4. Callaghan DA, Schwark WS. Pharmacological modification of amygdaloid-kindled seizures. Neuropharmacology. 1980;19:1131–1136
  5. Cohen AF, Land GS, Breimer DD, Yuen WC, Winton C, Peck AW. Lamotrigine, a new anticonvulsant: pharmacokinetics in normal humans. Clin. Pharmacol. Ther. 1987;42:535–541
  6. Coulter DA, Huguenard JR, Prince DA. Characterization of ethosuximide reduction of low-threshold calcium current in thalamic neurons. Ann. Neurol. 1989;25:582–593
  7. During MJ, Spencer DD. Extracellular hippocampal glutamate and spontaneous seizure in the conscious human brain (see comments). Lancet. 1993;341:1607–1610
  8. Ehle AL. Effects of phenytoin on amygdaloid kindled seizures in the rat. Electroencephalogr. Clin. Neurophysiol. 1980;48:102–105
  9. Geula C, Jarvie PA, Logan TC, Slevin JT. Long-term enhancement of K+-evoked release of l-glutamate in entorhinal kindled rats. Brain Res. 1988;442:368–372
  10. Griffith WH, Taylor L. Phenytoin reduces excitatory synaptic transmission and post-tetanic potentiation in the in vitro hippocampus. J. Pharmacol. Exp. Ther. 1988;246:851–858
  11. Jawad S, Richens A, Goodwin G, Yuen WC. Controlled trial of lamotrigine (Lamictal) for refractory partial seizures. Epilepsia. 1989;30:356–363
  12. Leach MJ, Marden CM, Miller AA. Pharmacological studies on lamotrigine, a novel potential antiepileptic drug: II. Neurochemical studies on the mechanism of action. Epilepsia. 1986;27:490–497
  13. Lorge M. Erfahrungen mit einem neuen Antiepilepticum, Tegtetol (G 32 883), mit besonderer Wirkung auf die epileptische WesensverSnderung. Schweiz Med. Wochensch. 1963;93:1042–1047
  14. Löscher W. Effects of the antiepileptic drug valproate on metabolism and function of inhibitory and excitatory amino acids in the brain. Neurochem. Res. 1993;18:485–502
  15. McNamara JO, Rigsbee LC, Butler LS, Shin C. Intravenous phenytoin is an effective anticonvulsant in the kindling model. Ann. Neurol. 1989;26:675–678
  16. Messenheimer JA. Lamotrigine. Epilepsia. 1995;36(Suppl. 2):87–94
  17. Miller AA, Wheatley P, Sawyer DA, Baxter MG, Roth B. Pharmacological studies on lamotrigine, a novel potential antiepileptic drug: I. Anticonvulsant profile in mice and rats. Epilepsia. 1986;27:483–489
  18. Morimoto K, Katayama K, Inoue K, Sato K. Effects of competitive and noncompetitive NMDA receptor antagonists on kindling and LTP. Pharmacol. Biochem. Behav. 1991;40:893–899
  19. Morimoto K, Sato H, Yamamoto Y, Watanabe T, Suwaki H. Antiepileptic effects of Tiagabine, a selective GABA uptake inhibitor, in the rat kindling model of temporal lobe epilepsy. Epilepsia. 1997;38:966–974
  20. Namba T, Morimoto K, Sato K, Yamada N, Kuroda S. Antiepileptogenic and anticonvulsant effects of NBQX, a selective AMPA receptor antagonist, in the kindling model of epilepsy. Brain Res. 1994;638:36–44
  21. O'Donnell RA, Miller AA. The effect of lamotrigine upon development of cortical kindled seizures in the rat. Neuropharmacology. 1991;30:253–258
  22. Peck, A.W., 1991. Clinical pharmacology of lamotrigine. Epilepsia 32 (Suppl. 2), S9–S12.
  23. Racine RJ. Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr. Clin. Neurophysiol. 1972;32:281–294
  24. Richens A, Dunlop A. Serum phenytoin levels in the management of epilepsy. Lancet. 1975;2:247–248
  25. Sato K, Morimoto M, Okamoto M. Anticonvulsant action of a non-competitive antagonist of NMDA receptors (MK-801) in the kindling model of epilepsy. Brain Res. 1988;463:12–20
  26. Schlumberger E, Chavez F, Palacios L, Rey E, Pajot N, Dulac O. Lamotrigine in treatment of 120 children with epilepsy. Epilepsia. 1994;35:359–367
  27. Teyler TJ, DiScenna P. Long-term potentiation. Annu. Rev. Neurosci. 1987;10:131–161
  28. Thompson P, Huppert FA, Trimble M. Phenytoin and cognitive function: effects on normal volunteers and implications for epilepsy. Br. J. Clin. Psychol. 1981;20:155–162
  29. Ueda Y, Tsuru N. Simultaneous monitoring of the seizure-related changes in extracellular glutamate and gamma-aminobutyric acid concentration in bilateral hippocampi following development of amygdaloid kindling. Epilepsy Res. 1995;20:213–219
  30. Wheatley PL, Miller AA. Effects of lamotrigine on electrically induced afterdischarge duration in anaesthetised rat, dog, and marmoset. Epilepsia. 1989;30:34–40
  31. Wilder, B.J., 1995. Phenytoin clinical use. In: Rene, H.L., Richard, H.M., Brain, S.M. (Eds.), Antiepileptic Drugs, 4th ed. Raven Press, New York, pp. 339–344.
  32. Yaari Y, Selzer ME, Pincus JH. Phenytoin: mechanisms of its anticonvulsant action. Ann. Neurol. 1986;20:171–184
  33. Yuen, A.W., 1994. Lamotrigine: a review of antiepileptic efficacy. Epilepsia 35 (Suppl. 5), S33–S36.

PII: S0920-1211(98)00018-7

Epilepsy Research
Volume 31, Issue 2 , Pages 101-112 , July 1998

Article Tools

* Image Usage & Resolution